Traditional and Emerging Antifungal Therapies
Proceedings of the American Thoracic Society · 15.05.2010 · 7 (3) · 222-228
DOI: 10.1513/pats.200906-048al ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Proceedings of the American Thoracic Society, online erschienen am 15.05.2010. Verfasst von Tamra M Arnold und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacy, Roudebush VA Medical Center, Indianapolis, Indiana, USA. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 77 Literaturangaben.
Abstract (Originalsprache)
Invasive mycoses continue to be a major problem in the growing population of immunosuppressed patients. More antifungal agents are now available than ever. The options are many, with more efficacies and less toxicity than in the past. These agents differ in terms of spectrum of activity, pharmacologic properties, and indications. In this article we discuss the three major classes of antifungal agents: the polyens, the triazoles, and the echinocandins. The emphasis is placed on their clinical use, side effects, drug interactions, and other practical issues.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacy, Roudebush VA Medical Center, Indianapolis, Indiana, USA.
Zitieren
APA
Arnold, T. M., Dotson, E., Sarosi, G. A., & Hage, C. A. (2010). Traditional and Emerging Antifungal Therapies. Proceedings of the American Thoracic Society, 7(3), 222-228. https://doi.org/10.1513/pats.200906-048al
Vancouver
Arnold TM, Dotson E, Sarosi GA, Hage CA. Traditional and Emerging Antifungal Therapies. Proceedings of the American Thoracic Society. 2010;7(3):222-228. doi:10.1513/pats.200906-048al
BibTeX
@article{Arnold2010,
author = {Arnold, Tamra M and Dotson, Emily and Sarosi, George A and Hage, Chadi A},
title = {Traditional and Emerging Antifungal Therapies},
journal = {Proceedings of the American Thoracic Society},
year = {2010},
volume = {7},
number = {3},
pages = {222--228},
doi = {10.1513/pats.200906-048al}
}
EUVIMED